Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Immune globulin

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wu J, et al. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy. Pediatric Rheumatology 21: No. 1, Dec 2023. Available from: URL: https://dx.doi.org/10.1186/s12969-023-00916-6 Wu J, et al. Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy. Pediatric Rheumatology 21: No. 1, Dec 2023. Available from: URL: https://​dx.​doi.​org/​10.​1186/​s12969-023-00916-6
Metadaten
Titel
Immune globulin
Lack of efficacy
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58214-x

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Bedaquiline

Case report

Multiple drugs

Case report

Ezetimibe/Niacin